The Women's Protection in Telehealth Act would exclude healthcare providers from Medicare participation if they prescribe, administer, dispense, or furnish abortion-inducing drugs outside of strict conditions. Specifically, only physicians who physically examine the patient, are present in the same room when the drug is administered, and schedule an in-person follow-up visit within 14 days would be permitted to provide these services while remaining eligible for Medicare. The bill defines abortion-inducing drugs as any substance intended to terminate a pregnancy with the knowledge it will cause fetal death, including off-label uses of existing medications. Any provider who violates these conditions would face permanent exclusion from the Medicare program with no opportunity for reinstatement or appeal. The legislation contains no specific funding allocations or implementation timelines beyond the effective date of enactment.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.